The objective of study is to estimate the sensitivity and specificity of the COR-DIAL based on nasopharyngeal samples taken at the patient's admission in relation to the final diagnosis of COVID-19 made by the medical team.
Diagnostic Test: COVID-19 RT-PCR
Nasopharyngeal swabs for COVID-19 RT-PCR
Diagnostic Test: Biosensor
Portable and Connected Biosensor viral
Inclusion Criteria:
- Male or female or child without age limit
- Admitted to a Reference Health Establishment in an emergency unit, hospitalisation or
intensive care unit for suspicion of SARS-CoV-2 infection, regardless of the clinical
presentation and degree of severity.
- Patient to be diagnosed using a PCR test on nasopharyngeal swab.
- Social insured
Exclusion Criteria:
- Atypical or suspicious cases without a final diagnosis of COVID-19 positive or
negative
- Patient refusal to participate
CHU lille
Lille, France
Investigator: Enagnon-Kazali ALIDJINOU, MD
Enagnon Kazali ALIDJINOU, MD
(0)3.20.44.45.97 - +33
EnagnonKazali.ALIDJINOU@CHRU-LILLE.FR
David Devos, MD,PhD
Enagnon Kazali ALIDJINOU, MD, Principal Investigator
University Hospital, Lille